M&A
Astellas’ Hostile Takeover Turns Even More Hostile
The Japan-based company filed a lawsuit against OSI Pharmaceuticals for rejecting its tender offer, but will this strategy work?
Regulatory
FDA Gives Red Light to Ranbaxy for Generic Flomax
The Indian generic firm Ranbaxy was dealt another blow this week as its version of the enlarged prostate drug Flomax was denied approval in the US just as it was about to go to market.
Marketing
Web Infinity—And Beyond!
Three ad agencies came up with two similarly designed ways of keeping track of online healthcare conversation, harnessing the power of social media sites like Twitter and Digg.
Global
Nothing is Rotten in the State of Denmark
Denmark is still on the fringes of some European Union policies. Notably, it has not yet embraced the euro as a currency, and it keeps its distance from the common defense policy. But in one respect, its pharmaceutical industry has just shown that it is well abreast—and even ahead—of EU developments.
Safety
US and Europe At Risk from Substandard Medicines
Recently, the public and policymakers have become more aware of the issue of counterfeit medicines — especially as patients increasingly learn about how to shop safely online for pharmaceuticals. But scant attention has been paid to a safety issue that is also important to patients: substandard medicines.
New & Noteworthy
Tearing Up the Rule Book
Sales compensation practices are due for an overhaul in 2010.
|
